We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.36B
AUM Growth
+$242M
Cap. Flow
+$106M
Cap. Flow %
4.48%
Top 10 Hldgs %
34.74%
Holding
3,215
New
294
Increased
1,348
Reduced
581
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Financials 7.56%
3 Healthcare 5.92%
4 Communication Services 5.21%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKT icon
2601
Rocket Companies
RKT
$38.9B
$2K ﹤0.01%
+110
New +$2.23K
RWK icon
2602
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.35B
$2K ﹤0.01%
26
SABR icon
2603
Sabre
SABR
$835M
$2K ﹤0.01%
180
FLNA
2604
Filana Therapeutics
FLNA
$48.1M
$2K ﹤0.01%
20
+10
+100% +$536
SBSI icon
2605
Southside Bancshares
SBSI
$967M
$2K ﹤0.01%
40
SCS
2606
DELISTED
Steelcase
SCS
$2K ﹤0.01%
144
+96
+200% +$1.38K
SFNC icon
2607
Simmons First National
SFNC
$3.39B
$2K ﹤0.01%
70
SHYF
2608
DELISTED
The Shyft Group
SHYF
$2K ﹤0.01%
53
SKYW icon
2609
Skywest
SKYW
$4.34B
$2K ﹤0.01%
50
+40
+400% +$1.97K
SM icon
2610
SM Energy
SM
$6.87B
$2K ﹤0.01%
+93
New +$1.8K
SSB icon
2611
SouthState Bank Corp
SSB
$10.5B
$2K ﹤0.01%
24
SSRM icon
2612
SSR Mining
SSRM
$6.48B
$2K ﹤0.01%
119
STR
2613
DELISTED
Sitio Royalties
STR
$2K ﹤0.01%
97
+43
+80% +$825
SYBT icon
2614
Stock Yards Bancorp
SYBT
$2.6B
$2K ﹤0.01%
35
TBPH icon
2615
Theravance Biopharma
TBPH
$877M
$2K ﹤0.01%
158
TGTX icon
2616
TG Therapeutics
TGTX
$7.62B
$2K ﹤0.01%
50
-14
-22% -$550
THO icon
2617
Thor Industries
THO
$4.14B
$2K ﹤0.01%
20
+4
+25% +$508
TIMB icon
2618
TIM SA
TIMB
$8.8B
$2K ﹤0.01%
173
+62
+56% +$720
TOTL icon
2619
State Street DoubleLine Total Return Tactical ETF
TOTL
$4B
$2K ﹤0.01%
44
TRNS icon
2620
Transcat
TRNS
$871M
$2K ﹤0.01%
+43
New +$2.24K
TRS icon
2621
TriMas Corp
TRS
$1.44B
$2K ﹤0.01%
+70
New +$2.22K
TU icon
2622
Telus
TU
$15.3B
$2K ﹤0.01%
+88
New +$1.91K
TWST icon
2623
Twist Bioscience
TWST
$7.25B
$2K ﹤0.01%
+14
New +$1.63K
TXG icon
2624
10x Genomics
TXG
$6.61B
$2K ﹤0.01%
11
-3,469
-100% -$628K
UFCS icon
2625
United Fire Group
UFCS
$1.4B
$2K ﹤0.01%
81

Similar funds

Parallel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Parallel Advisors held 3,215 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $106M of net new capital in Q2 2021, opening 294 new positions and adding to 1,348 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $8.53M trimmed.

  • Parallel Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.
  • Parallel Advisors added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $14.3M increase.
  • Parallel Advisors's biggest Q2 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $8.53M.
  • Parallel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $365K.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.36B portfolio in Q2 2021.
  • Parallel Advisors opened 294 new positions and closed 158 in Q2 2021.
  • Parallel Advisors's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.